EXACT Therapeutics AS (OB: EXTX)
Health Care · Biotechnology · NO
Nkr0.75
0.00% today · -68.8% 1Y
EXACT Therapeutics AS (OB: EXTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.10M.
Over the last twelve months the share price has lost 68.8%, trading between 0.58 and 2.98.
Tweenvest scores EXACT Therapeutics AS across four factors: quality 39/100, value 25/100. Its strongest factor is quality.
EXTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.10M
- Revenue (TTM)
- $5.85K
- P/E
- —
- EPS
- -1.37
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- Nkr2.98
- 52-week low
- Nkr0.58
- Avg volume (3M)
- —
- Shares outstanding
- 63.26M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.